AACR Annual Meeting 2023: The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
AACR Annual Meeting 2023: Clinical Trials of Therapeutic Cancer Vaccines Show Promise
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
AACR Annual Meeting 2023: Beating KRAS
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
AACR Annual Meeting 2023: Navigating the Challenges of Cancer Treatment During Pregnancy
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
AACR Annual Meeting 2023: Understanding Immune Suppression in Brain Metastases
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Global Scholar-in-Training Program Seeks 2023 Class of Awardees
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
Young Scientists from Around the World Benefit from AACR Support, Attendance at Annual Meeting
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
World Cancer Day 2025: How the AACR Is United by Unique
As World Cancer Day 2025 focuses on being "United by Unique," AACR shares how its initiatives help to connect...
World Cancer Day: AACR’s Efforts to Close the Care Gap
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Honoring National Cancer Survivors Month, Recognizing the AACR Scientist↔Survivor Program®’s Positive Impact
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 1, Trial Design)
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Driving Progress Against RAS-driven Cancers
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Editors’ Picks: April Highlights from AACR Journals
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Editors’ Picks: May Highlights from the AACR Journals
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
Giving Voice to the Need for Robust Cancer Research Funding
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
25 Years of Trastuzumab: A Legacy of Innovation
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
The More You Know About Cancer Prevention
Recent studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce who benefits from...
Dragging Oncogenes From the Cell: A New Horizon for Targeting KRAS
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
The Expanding Potential of Liquid Biopsy to Detect and Monitor Cancer
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
FDA Approvals in Oncology: July-September 2024
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Pride and (Health Care) Prejudice: Challenges Faced by LGBTQIA+ Cancer Patients
According to an annual Gallup poll that surveys approximately 10,000 U.S. adults, 7.2% of Americans aged 18 and older...
AACR Annual Meeting 2023: News and Highlights
The AACR Annual Meeting is where the cancer research community gathers to explore and expand the frontiers of discovery...
AACR Annual Meeting 2023
April 14-19, 2023Orange County Convention CenterOrlando, Florida aDVANCING THE Frontiers of Cancer Science and Medicine Regular Abstract Submission Opens:...
Meeting Resources
The regular abstracts presented at the AACR Annual Meeting 2023 are now available in PDF, epub, and mobi formats...
Exhibits
AACR Annual Meeting 2024 Mark your calendar! The AACR Annual Meeting 2024 will be held at the San Diego...
Continuing Medical Education
ACCREDITATION STATEMENT The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education...
NextGen Stars
AACR Annual Meeting 2023 NextGen Stars Program The NextGen Stars program provides an exciting opportunity to increase the visibility...
NextGen Stars
AACR Annual Meeting 2024 NextGen Stars Program The NextGen Stars program provided an exciting opportunity to increase the visibility...
Abstracts
Abstract Presentations The regular abstracts presented at the AACR Annual Meeting 2023 are available for download in PDF, epub,...